Abstract
Anorexia nervosa (AN) is a common condition in adolescents and young adults associated with hypogonadotropic hypogonadism (manifesting as functional hypothalamic amenorrhea), relative hypercortisolemia, a nutritionally acquired growth hormone resistance with low insulin-like growth factor-1 levels, low levels of leptin and oxytocin, and high levels of ghrelin and peptide YY. Low body mass index, reduced lean mass, and hormonal alterations contribute to low bone mineral density in adults and reduced bone accrual in adolescents with anorexia nervosa leading to an increased risk of fracture. A multidisciplinary treatment team is necessary to manage anorexia nervosa, with close monitoring of eating behaviors and weight changes. Weight gain and menses recovery result in improved bone mineral density, but residual deficits may persist. Calcium and vitamin D intake should be optimized in all. Transdermal 17β-estradiol in replacement doses with cyclic progesterone may be considered in mature adolescent girls with low and decreasing bone mineral density Z-scores, or evidence of skeletal fragility. Combined oral contraceptives are not effective in increasing bone mineral density and may mask spontaneous menstrual resumption. Bisphosphonates increase spine bone mineral density in adults with anorexia nervosa, but not adolescents. Their long half-life limits their use in this age group. Teriparatide increased spine bone mineral density in one study of older women with anorexia nervosa, but these data need to be confirmed with additional studies.
Abbreviations
- AN:
-
Anorexia nervosa
- BMD:
-
Bone mineral density
- DSM:
-
Diagnostic and statistical manual of mental disorders
- DXA:
-
Dual energy x-ray absorptiometry
- FHA:
-
Functional hypothalamic amenorrhea
- GH:
-
Growth hormone
- GnRH:
-
Gonadotropin releasing hormone
- IGF-1:
-
Insulin like growth factor-1
- IUD:
-
intrauterine device
- LH:
-
Luteinizing hormone
- Pref-1:
-
Preadipocyte factor-1
- PYY:
-
Peptide YY
- RANK-L:
-
Receptor activator of nuclear receptor kappa-ligand
- T3:
-
Triiodothyronine
- T4:
-
Thyroxine
- TSH:
-
Thyroid stimulating hormone
- vBMD:
-
Volumetric bone mineral density
References
Bachmann KN, Schorr M, Bruno AG et al (2017) Vertebral volumetric bone density and strength are impaired in women with low-weight and atypical anorexia nervosa. J Clin Endocrinol Metab 102:57–68
Baskaran C, Carson TL, Campoverde Reyes KJ et al (2017a) Macronutrient intake associated with weight gain in adolescent girls with anorexia nervosa. Int J Eat Disord 50:1050–1057
Baskaran C, Cunningham B, Plessow F et al (2017b) Estrogen replacement improves verbal memory and executive control in Oligomenorrheic/Amenorrheic athletes in a randomized controlled trial. J Clin Psychiatry 78:e490–e497
Baskaran C, Plessow F, Ackerman KE et al (2017c) A cross-sectional analysis of verbal memory and executive control across athletes with varying menstrual status and non-athletes. Psychiatry Res 258:605–606
Boyar RM, Hellman LD, Roffwarg H et al (1977) Cortisol secretion and metabolism in anorexia nervosa. N Engl J Med 296:190–193
Bredella MA, Fazeli PK, Miller KK et al (2009) Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab 94(6):2129–36
Divasta AD, Feldman HA, Giancaterino C et al (2012) The effect of gonadal and adrenal steroid therapy on skeletal health in adolescents and young women with anorexia nervosa. Metabolism 61:1010–1020
Donaldson AA, Feldman HA, O'donnell JM et al (2015) Spinal bone texture assessed by trabecular bone score in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 100:3436–3442
Duclos M, Corcuff JB, Roger P et al (1999) The dexamethasone-suppressed corticotrophin-releasing hormone stimulation test in anorexia nervosa. Clin Endocrinol 51:725–731
El Ghoch M, Calugi S, Chignola E et al (2016) Body fat and menstrual resumption in adult females with anorexia nervosa: a 1-year longitudinal study. J Hum Nutr Diet 29:662–666
Estour B, Pugeat M, Lang F et al (1990) Rapid escape of cortisol from suppression in response to i.v. dexamethasone in anorexia nervosa. Clin Endocrinol 33:45–52
Estour B, Germain N, Diconne E et al (2010) Hormonal profile heterogeneity and short-term physical risk in restrictive anorexia nervosa. J Clin Endocrinol Metab 95:2203–2210
Faje AT, Fazeli PK, Katzman DK et al (2012) Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls. Bone 51:474–479
Faje AT, Fazeli PK, Katzman D et al (2013a) Inhibition of Pref-1 (Preadipocyte factor 1) by Estradiol in adolescent girls with anorexia nervosa is associated with improvement in lumbar bone mineral density. Clin Endocrinol 79(3):326–32
Faje AT, Karim L, Taylor A et al (2013b) Adolescent girls with anorexia nervosa have impaired cortical and trabecular microarchitecture and lower estimated bone strength at the distal radius. J Clin Endocrinol Metab 98(5):1923–9
Faje AT, Fazeli PK, Miller KK et al (2014) Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa. Int J Eat Disord 47:458–466
Fazeli PK, Lawson EA, Prabhakaran R et al (2010a) Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 95:4889–4897
Fazeli PK, Misra M, Goldstein M et al (2010b) Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa. J Clin Endocrinol Metab 95:369–374
Fazeli PK, Wang IS, Miller KK et al (2014) Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa. J Clin Endocrinol Metab 99:1322–1329
Gatti D, El Ghoch M, Viapiana O et al (2015) Strong relationship between vitamin D status and bone mineral density in anorexia nervosa. Bone 78:212–215
Giollo A, Idolazzi L, Caimmi C et al (2017) Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa. Int J Eat Disord 50:1041–1049
Golabek K, Ostrowska Z, Ziora K et al (2015) Association between omentin-1, bone metabolism markers, and cytokines of the RANKL/RANK/OPG system in girls with anorexia nervosa. Endokrynol Pol 66:514–520
Golden NH, Jacobson MS, Schebendach J et al (1997) Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med 151:16–21
Golden NH, Iglesias EA, Jacobson MS et al (2005) Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 90:3179–3185
Gordon CM, Ackerman KE, Berga SL et al (2017) Functional hypothalamic amenorrhea: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 102:1413–1439
Grinspoon S, Baum H, Lee K et al (1996a) Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 81:3864–3870
Grinspoon S, Gulick T, Askari H et al (1996b) Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 81:3861–3863
Grinspoon S, Thomas E, Pitts S et al (2000) Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 133:790–794
Grinspoon S, Thomas L, Miller K et al (2002) Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 87:2883–2891
Hadigan CM, Anderson EJ, Miller KK et al (2000) Assessment of macronutrient and micronutrient intake in women with anorexia nervosa. Int J Eat Disord 28:284–292
Kandemir N, Becker K, Slattery M et al (2017) Impact of low-weight severity and menstrual status on bone in adolescent girls with anorexia nervosa. Int J Eat Disord 50:359–369
Klibanski A, Biller B, Schoenfeld D et al (1995) The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 80:898–904
Kluge M, Schussler P, Schmidt D et al (2012) Ghrelin suppresses secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in women. J Clin Endocrinol Metab 97:E448–E451
Lawson EA, Donoho D, Miller KK et al (2009) Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab 94:4710–4716
Lawson EA, Miller KK, Bredella MA et al (2010) Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone 46:458–463
Lawson EA, Donoho DA, Blum JI et al (2011) Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass. J Clin Psychiatry 72:1546–1551
Miller KK, Lee EE, Lawson EA et al (2006) Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab 91:2931–2937
Miller KK, Wexler TL, Zha AM et al (2007) Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. J Clin Psychiatry 68:959–965
Miller KK, Meenaghan E, Lawson EA et al (2011) Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study. J Clin Endocrinol Metab 96:2081–2088
Milos G, Spindler A, Ruegsegger P et al (2005) Cortical and trabecular bone density and structure in anorexia nervosa. Osteoporos Int 16:783–790
Misra M, Klibanski A (2014) Endocrine consequences of anorexia nervosa. Lancet Diabetes Endocrinol 2:581–592
Misra M, Miller KK, Bjornson J et al (2003a) Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 88:5615–5623
Misra M, Soyka LA, Miller KK et al (2003b) Serum osteoprotegerin in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 88:3816–3822
Misra M, Aggarwal A, Miller KK et al (2004a) Effects of anorexia nervosa on clinical, hematologic, biochemical, and bone density parameters in community-dwelling adolescent girls. Pediatrics 114:1574–1583
Misra M, Miller KK, Almazan C et al (2004b) Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 89:4972–4980
Misra M, Miller KK, Herzog DB et al (2004c) Growth hormone and ghrelin responses to an oral glucose load in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab 89:1605–1612
Misra M, Miller KK, Almazan C et al (2005a) Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls. J Clin Endocrinol Metab 90:2580–2587
Misra M, Miller KK, Kuo K et al (2005b) Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 289:E347–E356
Misra M, Miller KK, Kuo K et al (2005c) Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab 289:E373–E381
Misra M, Miller KK, Tsai P et al (2006a) Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 91:1027–1033
Misra M, Prabhakaran R, Miller KK et al (2006b) Role of cortisol in menstrual recovery in adolescent girls with anorexia nervosa. Pediatr Res 59:598–603
Misra M, Tsai P, Anderson EJ et al (2006c) Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutr 84:698–706
Misra M, Katzman DK, Cord J et al (2008a) Bone metabolism in adolescent boys with anorexia nervosa. J Clin Endocrinol Metab 93:3029–3036
Misra M, Katzman DK, Cord J et al (2008b) Percentage extremity fat, but not percentage trunk fat, is lower in adolescent boys with anorexia nervosa than in healthy adolescents. Am J Clin Nutr 88:1478–1484
Misra M, Prabhakaran R, Miller KK et al (2008c) Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab 93:1231–1237
Misra M, Mcgrane J, Miller KK et al (2009) Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa. Bone 45:493–498
Misra M, Le Clair M, Mendes N et al (2010) Use of SSRIs may impact bone density in adolescent and young women with anorexia nervosa. CNS Spectr 15:579–586
Misra M, Katzman D, Miller KK et al (2011) Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res 26:2430–2438
Misra M, Katzman DK, Estella NM et al (2013) Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial. J Clin Psychiatry 74:e765–e771
Nakazato M, Murakami N, Date Y et al (2001) A role for ghrelin in the central regulation of feeding. Nature 409:194–198
Peterson CB, Pisetsky EM, Swanson SA et al (2016) Examining the utility of narrowing anorexia nervosa subtypes for adults. Compr Psychiatry 67:54–58
Robinson L, Micali N, Misra M (2017) Eating disorders and bone metabolism in women. Curr Opin Pediatr 29:488–496
Schorr M, Thomas JJ, Eddy KT et al (2017) Bone density, body composition, and psychopathology of anorexia nervosa spectrum disorders in DSM-IV vs DSM-5. Int J Eat Disord 50:343–351
Sedlackova D, Kopeckova J, Papezova H et al (2012) Comparison of a high-carbohydrate and high-protein breakfast effect on plasma ghrelin, obestatin, NPY and PYY levels in women with anorexia and bulimia nervosa. Nutr Metab (Lond) 9:52
Sienkiewicz E, Magkos F, Aronis KN et al (2011) Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women. Metabolism 60:1211–1221
Singhal V, Maffazioli GD, Ackerman KE et al (2016) Effect of chronic athletic activity on Brown fat in young women. PLoS One 11:e0156353
Singhal V, Tulsiani S, Campoverde KJ et al (2018) Impaired bone strength estimates at the distal tibia and its determinants in adolescents with anorexia nervosa. Bone 106:61–68
Soyka LA, Misra M, Frenchman A et al (2002) Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 87:4177–4185
Stock S, Leichner P, Wong AC et al (2005) Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 90:2161–2168
Stoving RK, Veldhuis JD, Flyvbjerg A et al (1999) Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis. J Clin Endocrinol Metab 84:2056–2063
Strokosch GR, Friedman AJ, Wu SC et al (2006) Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. J Adolesc Health 39:819–827
Utz AL, Lawson EA, Misra M et al (2008) Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone 43:135–139
Vestergaard P, Emborg C, Stoving RK et al (2002) Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders – a nationwide register study. Int J Eat Disord 32:301–308
Welt CK, Chan JL, Bullen J et al (2004) Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 351:987–997
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
Misra, M. (2018). Endocrine Aspects of Anorexia Nervosa. In: Preedy, V., Patel, V. (eds) Handbook of Famine, Starvation, and Nutrient Deprivation. Springer, Cham. https://doi.org/10.1007/978-3-319-40007-5_115-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-40007-5_115-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40007-5
Online ISBN: 978-3-319-40007-5
eBook Packages: Springer Reference MedicineReference Module Medicine